Similar articles

• COPD and declining FEV1--time to divide and conquer?

  Reilly JJ. Reilly JJ. N Engl J Med. 2008 Oct 9;359(15):1616-8. doi: 10.1056/NEJMe0807387. Epub 2008 Oct 5. N Engl J Med. 2008. PMID: 18836214 No abstract available.
• Tiotropium in chronic obstructive pulmonary disease.

  Chang ET. Chang ET. N Engl J Med. 2009 Jan 8;360(2):185; author reply 187. N Engl J Med. 2009. PMID: 19137623 No abstract available.
• The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.

  Tashkin DP. Tashkin DP. Am J Med. 2006 Oct;119(10 Suppl 1):63-72. doi: 10.1016/j.amjmed.2006.08.009. Am J Med. 2006. PMID: 16996901 Review.
• Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial.

  Decramer M, Celli B, Kesten S, Lystig T, Mehra S, Tashkin DP; UPLIFT investigators. Decramer M, et al. Lancet. 2009 Oct 3;374(9696):1171-8. doi: 10.1016/S0140-6736(09)61298-8. Epub 2009 Aug 27. Lancet. 2009. PMID: 19716598 Clinical Trial.
• [Tiotropium--the "surgical" drug].

  Mihălţan F. Mihălţan F. Pneumologia. 2004 Oct-Dec;53(4):189-92. Pneumologia. 2004. PMID: 16106727 Review. Romanian. No abstract available.